You hua Yuan

Dr. You hua Yuan

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2019 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
YYYou hua Yuan
You hua Yuan
JWJunjie Wang
Junjie Wang
JZJiangfeng Zhang
Jiangfeng Zhang
BMBing Ma
Bing Ma
SGShanjun Gao
Shanjun Gao
NJNan Jing
Nan Jing
Background: Although various methods have been developed to directly identify bacteria from positive blood cultures by matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS), the necessity of using commercial kits still leads to a high cost and long assay time. Moreover, few evaluations of these methods have been conducted. This study aimed to evaluate the feasibility of an optimized MALDI‐TOF MS method for direct identification of bacteria in positive blood cultures. Methods: A total of 829 non‐repeated positive cultures were collected from July 2018 to August 2019, and direct identification was performed by an optimized MALDI‐TOF MS method. The same positive blood cultures were sub‐cultivated to obtain a single bacterial colony and identified by classical biochemical BD testing, which is the gold standard to compare the accuracy of direct identification of positive blood cultures by MALDI‐TOF MS. Results: After excluding 7 false‐positive samples from the 829 positive blood cultures, the most accurate rate of direct identification by this optimized MALDI‐TOF MS method was for gram‐negative bacteria (91.5%), followed by gram‐positive bacteria (88.3%), fungi (84.8%), anaerobic bacteria (80%), and other rare bacteria (66.67%). Conclusion: Common bacteria in positive blood cultures can be identified directly within 1 hour by MALDI‐TOF MS, and thus, this optimized method can be used as a primary identification method by clinicians. Routine implementation of this method may significantly increase the optimal utilization rate of antibiotics and decrease mortality in bacteremia patients.

20 September 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
HWHuiling Wang
Huiling Wang
JZJing Zhao
Jing Zhao
XLXiaoli Liu
Xiaoli Liu
WYWenjuan Yan
Wenjuan Yan
GLGang Li
Gang Li
YYYou hua Yuan
You hua Yuan
Background: This paper aimed to assess the prevalence of human papillomavirus (HPV) infection and the associations of sociodemographic and behavioral characteristics with HPV in unvaccinated men in Henan Province before the mass administration of the HPV vaccine through a baseline survey.Methods: Between June 2015 to June 2020, 3,690 men were tested for the HPV genotype at the Henan Provincial People's Hospital. The HPV genotype was detected by a polymerase chain reaction (PCR)-based hybridization gene chip assay.Results: The overall HPV infection rate was 29.97%; The most prevalent genotypes were HPV 6 (21.76%), 11 (12.68%), 16 (8.94%), 58 (5.37%), 18 (3.41%), 84 (3.25%), 61 (3.09%), and 81 (3.09%). Low-risk HPV (LR-HPV) infection (24.91%) and single infection (17.78%) were the most prevalent forms. Age-specific HPV distribution was presented as a bimodal curve; the youngest age group (≤ 25 years) had the highest HPV infection rate (36.03%), followed by the 36–40-year-old group (33.68%). Men with Junior high school or above were more likely to have Pure-LR HPV infection. Unmarried status and smoking increased single and LR-HPV infection. Multiple lifetime sex partners and not using a condom were more likely to cause LR-HPV infection.Conclusions: The data on the prevalence and HPV infection type distribution in men in Henan Province could serve as a valuable reference to guide nationwide screening. We provide a time-based estimate of the maximum impact of the HPV vaccine and critical reference measurements important for assessing the clinical benefits of HPV vaccination and the increase in non-vaccine HPV types.

23 December 2021 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
QZQiongrui Zhao
Qiongrui Zhao
YYYou hua Yuan
You hua Yuan
JZJiangfeng Zhang
Jiangfeng Zhang
JLJieren Li
Jieren Li
WLWei Li
Wei Li
QZQi Zhang
Qi Zhang
Background: Limited research has been conducted on early laboratory biomarkers to identify patients with severe coronavirus disease (COVID‐19). This study fills this gap to ensure appropriate treatment delivery and optimal resource utilization.Methods: In this retrospective, multicentre, cohort study, 52 and 64 participants with severe and mild cases of COVID‐19, respectively, were enrolled during January‐March 2020. Least absolute shrinkage and selection operator and binary forward stepwise logistic regression were used to construct a predictive risk score. A prediction model was then developed and verified using data from four hospitals.Results: Of the 50 variables assessed, eight were independent predictors of COVID‐19 and used to calculate risk scores for severe COVID‐19: age (odds ratio (OR = 14.01, 95% confidence interval (CI) 2.1–22.7), number of comorbidities (OR = 7.8, 95% CI 1.4–15.5), abnormal bilateral chest computed tomography images (OR = 8.5, 95% CI 4.5–10), neutrophil count (OR = 10.1, 95% CI 1.88–21.1), lactate dehydrogenase (OR = 4.6, 95% CI 1.2–19.2), C‐reactive protein OR = 16.7, 95% CI 2.9–18.9), haemoglobin (OR = 16.8, 95% CI 2.4–19.1) and D‐dimer levels (OR = 5.2, 95% CI 1.2–23.1). The model was effective, with an area under the receiver‐operating characteristic curve of 0.944 (95% CI 0.89–0.99, p < 0.001) in the derived cohort and 0.8152 (95% CI 0.803–0.97; p < 0.001) in the validation cohort.Conclusion: Predictors based on the characteristics of patients with COVID‐19 at hospital admission may help predict the risk of subsequent critical illness.

14 April 2020 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
RCRuifei Chen
Ruifei Chen
XQXinkun Qi
Xinkun Qi
BMBing Ma
Bing Ma
PXPoshi Xu
Poshi Xu
YYYou hua Yuan
You hua Yuan

30 August 2024 in Medicine
Verified
Journal Article
Open access
YYYou hua Yuan
You hua Yuan
WTWenqian Tian
Wenqian Tian
XWXiaoxia Wei
Xiaoxia Wei
YZYa Zhu
Ya Zhu
FLFengzhen Liu
Fengzhen Liu
XZXiaohuan Zhang
Xiaohuan Zhang
The use of 3 biomarkers – cystatin-C (Cys-C), retinol-binding protein (RBP), and ischemia-modified albumin (IMA) – for the clinical classification and outcome of coronary heart disease (CHD) has not been adequately evaluated. We explored the serum levels of these 3 markers and evaluated their diagnostic and prognostic values in patients with CHD. This retrospective case–control study, conducted between June 2017 and June 2018, included 201 patients with CHD hospitalized at the Henan Provincial People’s Hospital and 127 healthy individuals from Henan Provincial People’s Hospital as controls. Cys-C, RBP, IMA levels, and other laboratory parameters in the 2 groups were determined, and patient outcomes were analyzed. Cys-C, RBP, and IMA levels were higher in the case group than in the control group (P < .05). Logistic regression analysis confirmed that these 3 biomarkers were independent risk factors for CHD. Each indicator has clinical significance in the diagnosis and prognosis of CHD, with RBP being the most significant. The AUC value for CHD detection using a combination of the 3 indicators was 0.783, and the sensitivity and specificity values were 78% and 74.6%, respectively. Simultaneous detection of Cys-C, RBP, and IMA could be an optimal method for early diagnosis and prognosis of CHD.

12 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
BMBing Ma
Bing Ma
YTYunqi Tian
Yunqi Tian
YHYungang Han
Yungang Han
LBLifang Ban
Lifang Ban
JYJunwen Yang
Junwen Yang
YLYi Li
Yi Li
Nocardia is an important cause of clinically invasive disease, but for most clinical laboratories, identification of these isolates to the species level is challenging. Recently, matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been widely used for identification of most bacterial and fungal isolates. In this multicenter study, we evaluated the identification of Nocardia isolates using Autof MS1000 and Bruker Biotyper. A total of 86 non-duplicate Nocardia isolates from 7 hospital laboratories were evaluated. Further, we carried out sequence analysis of 16S rRNA, gyrB, secA1, hsp65 , and rpoB genes as a reference method for Nocardia species identification. The 86 isolates were directly spotted on the target plate and plate protein extraction was performed. Data were analyzed by SPSS 19.0. In total, 72 (83.7%) strains (score ≥ 9.0) and 70 (81.4%) strains (score ≥ 2.0) were correctly identified by the Autof MS1000 and Bruker Biotyper systems, respectively, at the species level. There was no significant difference (P > 0.05) between the two systems using the same protein extraction method. In conclusion, the Autof MS 1000 and Bruker MALDI-TOF systems showed no difference in identification of Nocardia spp . to the species level and could meet the most important clinical requirement for species identification.